{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:41:15Z","timestamp":1792737675290,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejrad.2026.113258","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:21:18Z","timestamp":1790205678000},"page":"113258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Risk-adapted imaging of gastric neuroendocrine neoplasms: an entity-, type-, and grade-informed framework for staging and management"],"prefix":"10.1016","volume":"205","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5066-3633","authenticated-orcid":false,"given":"Yujian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejrad.2026.113258_b0005","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol."},{"issue":"18","key":"10.1016\/j.ejrad.2026.113258_b0010","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after carcinoid: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ejrad.2026.113258_b0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr. Pathol."},{"key":"10.1016\/j.ejrad.2026.113258_b0020","unstructured":"WHO Classification of Tumours Editorial Board. Digestive System Tumours. 5th ed. Vol. 1. Lyon (France): International Agency for Research on Cancer, 2019."},{"issue":"Suppl. 1","key":"10.1016\/j.ejrad.2026.113258_b0025","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1530\/ERC-11-0013","article-title":"Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms","volume":"18","author":"Kl\u00f6ppel","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"issue":"3","key":"10.1016\/j.ejrad.2026.113258_b0030","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s12020-017-1364-8","article-title":"Ki-67 heterogeneity in well-differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment?","volume":"57","author":"Grillo","year":"2017","journal-title":"Endocrine"},{"issue":"14","key":"10.1016\/j.ejrad.2026.113258_b0035","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.2217\/fon.14.139","article-title":"PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature","volume":"10","author":"Johnbeck","year":"2014","journal-title":"Future Oncol."},{"issue":"1","key":"10.1016\/j.ejrad.2026.113258_b0040","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13359","article-title":"Use and perceived utility of 18F-FDG PET\/CT in neuroendocrine neoplasms: a consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022","volume":"36","author":"Ambrosini","year":"2024","journal-title":"J. Neuroendocrinol."},{"issue":"6","key":"10.1016\/j.ejrad.2026.113258_b0045","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/MPA.0b013e3181ebb168","article-title":"NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas","volume":"39","author":"Kulke","year":"2010","journal-title":"Pancreas"},{"issue":"2","key":"10.1016\/j.ejrad.2026.113258_b0050","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1530\/EJE-12-0836","article-title":"Long-term follow-up of a large series of patients with type 1 gastric carcinoid tumors: data from a multicenter study","volume":"168","author":"Thomas","year":"2013","journal-title":"Eur. J. Endocrinol."},{"issue":"12","key":"10.1016\/j.ejrad.2026.113258_b0055","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/apt.15765","article-title":"Systematic review: management of localised low-grade upper gastrointestinal neuroendocrine tumours","volume":"51","author":"Exarchou","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"46","key":"10.1016\/j.ejrad.2026.113258_b0060","doi-asserted-by":"crossref","first-page":"8687","DOI":"10.3748\/wjg.v19.i46.8687","article-title":"Metastatic type 1 gastric carcinoid: a real threat or just a myth?","volume":"19","author":"Grozinsky-Glasberg","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.ejrad.2026.113258_b0065","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13306","article-title":"European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1\u2013G3","volume":"35","author":"Panzuto","year":"2023","journal-title":"J. Neuroendocrinol."},{"issue":"4","key":"10.1016\/j.ejrad.2026.113258_b0070","doi-asserted-by":"crossref","first-page":"525","DOI":"10.5946\/ce.2024.343","article-title":"A systematic review on endoscopic ultrasound in gastric neuroendocrine neoplasms: guidelines outpacing evidence","volume":"58","author":"Marasco","year":"2025","journal-title":"Clin Endosc."},{"issue":"9","key":"10.1016\/j.ejrad.2026.113258_b0075","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1365-2036.2006.03130.x","article-title":"Review article: pathogenesis and management of gastric carcinoid tumours","volume":"24","author":"Burkitt","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.ejrad.2026.113258_b0080","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000335595","article-title":"ENETS consensus guidelines for the management of patients with gastroduodenal neoplasms","volume":"95","author":"Delle Fave","year":"2012","journal-title":"Neuroendocrinology"},{"issue":"4","key":"10.1016\/j.ejrad.2026.113258_b0085","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13267","article-title":"All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: a thorough update","volume":"35","author":"Chatzipanagiotou","year":"2023","journal-title":"J. Neuroendocrinol."},{"issue":"8","key":"10.1016\/j.ejrad.2026.113258_b0090","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.3390\/cancers15082202","article-title":"Gastric neuroendocrine tumors (g-NETs): a systematic review of the management and outcomes of type 3 g-NETs","volume":"15","author":"Laffi","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ejrad.2026.113258_b0095","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12020-021-02775-1","article-title":"Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms?","volume":"74","author":"Exarchou","year":"2021","journal-title":"Endocrine"},{"issue":"10","key":"10.1016\/j.ejrad.2026.113258_b0100","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1634\/theoncologist.2015-0476","article-title":"Gastroenteropancreatic well-differentiated grade 3 neuroendocrine tumors: review and position statement","volume":"21","author":"Coriat","year":"2016","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.ejrad.2026.113258_b0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/cancers4010011","article-title":"Mixed adenoneuroendocrine carcinomas (MANECs) of the gastrointestinal tract: an update","volume":"4","author":"La Rosa","year":"2012","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.ejrad.2026.113258_b0110","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000475527","article-title":"Digestive system mixed neuroendocrine-non-neuroendocrine neoplasms","volume":"105","author":"de Mestier","year":"2017","journal-title":"Neuroendocrinology"},{"issue":"8","key":"10.1016\/j.ejrad.2026.113258_b0115","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/00000478-200608000-00003","article-title":"Gastric large cell neuroendocrine carcinomas: a distinct clinicopathologic entity","volume":"30","author":"Jiang","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"issue":"7","key":"10.1016\/j.ejrad.2026.113258_b0120","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/PAS.0b013e31828ff59d","article-title":"Neuroendocrine carcinoma of the stomach: morphologic and immunohistochemical characteristics and prognosis","volume":"37","author":"Ishida","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"issue":"9","key":"10.1016\/j.ejrad.2026.113258_b0125","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.70272","article-title":"Differences in endoscopic features of gastric neuroendocrine tumor and neuroendocrine carcinoma from a clinicopathological perspective","volume":"9","author":"Matsueda","year":"2025","journal-title":"JGH Open."},{"issue":"3","key":"10.1016\/j.ejrad.2026.113258_b0130","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13249","article-title":"European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma","volume":"35","author":"Sorbye","year":"2023","journal-title":"J. Neuroendocrinol."},{"issue":"7","key":"10.1016\/j.ejrad.2026.113258_b0135","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.annonc.2020.03.304","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Pavel","year":"2020","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.ejrad.2026.113258_b0140","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000329043","article-title":"Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate","volume":"95","author":"Merola","year":"2012","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10.1016\/j.ejrad.2026.113258_b0145","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1023\/A:1017972204219","article-title":"Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection","volume":"47","author":"Sato","year":"2002","journal-title":"Dig. Dis. Sci."},{"issue":"10","key":"10.1016\/j.ejrad.2026.113258_b0150","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/jgh.16309","article-title":"Endoscopic features of gastric neuroendocrine carcinoma","volume":"38","author":"Matsueda","year":"2023","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.ejrad.2026.113258_b0155","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1055\/a-1751-5742","article-title":"Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) Guideline","volume":"54","author":"Deprez","year":"2022","journal-title":"Endoscopy"},{"issue":"1","key":"10.1016\/j.ejrad.2026.113258_b0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.2005.01.013","article-title":"Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging","volume":"23","author":"Dromain","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.ejrad.2026.113258_b0165","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.1007\/s00330-020-06930-6","article-title":"The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor","volume":"30","author":"Hayoz","year":"2020","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2026.113258_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2024.111710","article-title":"Head-to-head comparison of contrast-enhanced CT, dual-layer spectral-detector CT, and Gd-EOB-DTPA-enhanced MR in detecting neuroendocrine tumor liver metastases","volume":"181","author":"Xie","year":"2024","journal-title":"Eur. J. Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2026.113258_b0175","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1148\/rg.271065169","article-title":"From the archives of the AFIP: gastrointestinal carcinoids: imaging features with clinicopathologic comparison","volume":"27","author":"Levy","year":"2007","journal-title":"Radiographics"},{"issue":"12","key":"10.1016\/j.ejrad.2026.113258_b0180","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1007\/s00261-022-03509-1","article-title":"Gastric neuroendocrine neoplasms: a primer for radiologists","volume":"47","author":"Roseland","year":"2022","journal-title":"Abdom Radiol (NY)."},{"issue":"1","key":"10.1016\/j.ejrad.2026.113258_b0185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1148\/rg.231025071","article-title":"Current role of CT in imaging of the stomach","volume":"23","author":"Horton","year":"2003","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.ejrad.2026.113258_b0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1148\/radiol.12112512","article-title":"Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management","volume":"266","author":"Sahani","year":"2013","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.ejrad.2026.113258_b0195","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000471879","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine and hybrid imaging","volume":"105","author":"Sundin","year":"2017","journal-title":"Neuroendocrinology"},{"issue":"2","key":"10.1016\/j.ejrad.2026.113258_b0200","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1148\/rg.352140164","article-title":"Somatostatin receptor imaging with 68Ga-DOTATATE PET\/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation","volume":"35","author":"Hofman","year":"2015","journal-title":"Radiographics"},{"issue":"2","key":"10.1016\/j.ejrad.2026.113258_b0205","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2967\/jnumed.122.264860","article-title":"SNMMI Procedure Standard\/EANM Practice Guideline for SSTR PET: imaging neuroendocrine tumors","volume":"64","author":"Hope","year":"2023","journal-title":"J. Nucl. Med."},{"issue":"2","key":"10.1016\/j.ejrad.2026.113258_b0210","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 trial of 177Lu-DOTATATE for midgut neuroendocrine tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ejrad.2026.113258_b0215","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2967\/jnumed.115.163865","article-title":"Safety and efficacy of 68Ga-DOTATATE PET\/CT for diagnosis, staging, and treatment management of neuroendocrine tumors","volume":"57","author":"Deppen","year":"2016","journal-title":"J. Nucl. Med."},{"issue":"4","key":"10.1016\/j.ejrad.2026.113258_b0220","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-24-0231","article-title":"Management of high-grade neuroendocrine neoplasms: impact of functional imaging","volume":"32","author":"Islam","year":"2025","journal-title":"Endocr. Relat. Cancer"},{"issue":"5","key":"10.1016\/j.ejrad.2026.113258_b0225","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.7150\/thno.18068","article-title":"Dual somatostatin receptor\/FDG PET\/CT imaging in metastatic neuroendocrine tumours: proposal for a novel grading scheme with prognostic significance","volume":"7","author":"Chan","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.ejrad.2026.113258_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.109662","article-title":"Radiomics analysis of CT imaging for differentiating gastric neuroendocrine carcinomas from gastric adenocarcinomas","volume":"138","author":"Wang","year":"2021","journal-title":"Eur. J. Radiol."},{"issue":"12","key":"10.1016\/j.ejrad.2026.113258_b0235","doi-asserted-by":"crossref","first-page":"8190","DOI":"10.21037\/qims-23-577","article-title":"Deep learning radiomics analysis based on computed tomography for survival prediction in gastric neuroendocrine neoplasm: a multicenter study","volume":"13","author":"Yang","year":"2023","journal-title":"Quant. Imaging Med. Surg."},{"key":"10.1016\/j.ejrad.2026.113258_b0240","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1480466","article-title":"Synergizing traditional CT imaging with radiomics: a novel model for preoperative diagnosis of gastric neuroendocrine and mixed adenoneuroendocrine carcinoma","volume":"14","author":"He","year":"2024","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ejrad.2026.113258_b0245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00261-015-0593-7","article-title":"Neuroendocrine carcinoma of the stomach: clinical features and CT findings","volume":"41","author":"Liang","year":"2016","journal-title":"Abdom Radiol (NY)."},{"issue":"3","key":"10.1016\/j.ejrad.2026.113258_b0250","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2214\/ajr.184.3.01840803","article-title":"Gastrointestinal stromal tumors: clinical, radiologic, and pathologic features","volume":"184","author":"Sandrasegaran","year":"2005","journal-title":"AJR Am. J. Roentgenol."},{"issue":"5","key":"10.1016\/j.ejrad.2026.113258_b0255","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1148\/rg.275065151","article-title":"Primary gastrointestinal lymphoma: spectrum of imaging findings with pathologic correlation","volume":"27","author":"Ghai","year":"2007","journal-title":"Radiographics"},{"issue":"2","key":"10.1016\/j.ejrad.2026.113258_b0260","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1148\/rg.2017160091","article-title":"Heterotopic pancreas: histopathologic features, imaging findings, and complications","volume":"37","author":"Rezvani","year":"2017","journal-title":"Radiographics"},{"issue":"9","key":"10.1016\/j.ejrad.2026.113258_b0265","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.70260","article-title":"Step-by-step approach to the incidental diagnosis of type I gastric neuroendocrine tumors: practical insights","volume":"9","author":"Baldini","year":"2025","journal-title":"JGH Open."},{"issue":"5","key":"10.1016\/j.ejrad.2026.113258_b0270","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2967\/jnumed.124.268621","article-title":"PET- and CT-based imaging criteria for response assessment of gastroenteropancreatic neuroendocrine tumors under radiopharmaceutical therapy","volume":"66","author":"Herr","year":"2025","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.ejrad.2026.113258_b0275","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3390\/jcm11061641","article-title":"Usefulness of 68-Gallium PET in type I gastric neuroendocrine neoplasia: a case series","volume":"11","author":"Rinzivillo","year":"2022","journal-title":"J. Clin. Med."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26006066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X26006066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:32:55Z","timestamp":1792737175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X26006066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":55,"alternative-id":["S0720048X26006066"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.113258","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk-adapted imaging of gastric neuroendocrine neoplasms: an entity-, type-, and grade-informed framework for staging and management","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2026.113258","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113258"}}